Miragen Therapeutics, Inc. (MGEN) financial statements (2021 and earlier)

Company profile

Business Address 6200 LOOKOUT ROAD
BOULDER, CO 80301
State of Incorp. DE
Fiscal Year End December 31
SIC 8071 - Medical Laboratories (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1282762473115
Cash and cash equivalents  33473115
Short-term investments82230    
Other undisclosed cash, cash equivalents, and short-term investments4625     
Restricted cash and investments      0
Receivables 001101
Inventory, net of allowances, customer advances and progress billings    000
Inventory    000
Deferred costs   0   
Assets held-for-sale, not part of disposal group    0 
Other undisclosed current assets2333000
Total current assets:1303065524127
Noncurrent Assets
Operating lease, right-of-use asset0 
Property, plant and equipment0111 11
Deferred costs      0
Other noncurrent assets1 00   
Other undisclosed noncurrent assets     00
Total noncurrent assets:2111 11
TOTAL ASSETS:1313066524138
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities10644411
Accounts payable1111000
Accrued liabilities10543310
Employee-related liabilities      0
Deferred revenue0 
Debt 42   0
Due to related parties    111
Other liabilities    00 
Other undisclosed current liabilities      (0)
Total current liabilities:111074522
Noncurrent Liabilities
Long-term debt and lease obligation 4810   
Long-term debt, excluding current maturities 4810   
Liabilities, other than long-term debt1 00 00
Other liabilities1 00 00
Total noncurrent liabilities:14810 00
Total liabilities:11151514522
Stockholders' equity
Stockholders' equity attributable to parent, including:120165139(0)106
Common stock0000000
Additional paid in capital218184177132302813
Accumulated other comprehensive loss(0) (0)    
Accumulated deficit(279)(168)(126)(94)(31)(18)(7)
Other undisclosed stockholders' equity attributable to parent181      
Total stockholders' equity:120165139(0)106
TOTAL LIABILITIES AND EQUITY:1313066524138

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues1484366
Revenue, net4334
Cost of revenue    (3)(2)(3)
Gross profit:1484133
Operating expenses(111)(46)(41)(31)(13)(14)(11)
Other undisclosed operating income (loss)     (1)1
Operating loss:(110)(42)(33)(27)(13)(11)(7)
Nonoperating income (expense)0110  (0)
Loss on contract termination      (0)
Interest and debt expense(1)(1)(1)(0)(0)(0)(1)
Net loss:(111)(42)(33)(27)(13)(11)(8)
Other undisclosed net income attributable to parent      0
Net loss attributable to parent:(111)(42)(33)(27)(13)(11)(8)
Preferred stock dividends and other adjustments   (0)   
Net loss available to common stockholders, diluted:(111)(42)(33)(27)(13)(11)(8)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(111)(42)(33)(27)(13)(11)(8)
Comprehensive loss:(111)(42)(33)(27)(13)(11)(8)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)0(0)    
Comprehensive loss, net of tax, attributable to parent:(111)(42)(33)(27)(13)(11)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: